1
|
Cao L, Liu J, Li Y, Xie D, Yan Q, Li Q, Cao Y, Du W, Li J, Ye Z, Zhou D, Kang C, Cao S. Biological Characteristics of Feline Calicivirus Epidemic Strains in China and Screening of Broad-Spectrum Protective Vaccine Strains. Vaccines (Basel) 2023; 11:1858. [PMID: 38140261 PMCID: PMC10747013 DOI: 10.3390/vaccines11121858] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2023] [Revised: 12/02/2023] [Accepted: 12/11/2023] [Indexed: 12/24/2023] Open
Abstract
Feline calicivirus (FCV) is one of the most important pathogens causing upper respiratory tract diseases in cats, posing a serious health threat to these animals. At present, FCV is mainly prevented through vaccination, but the protective efficacy of vaccines in China is limited. In this study, based on the differences in capsid proteins of isolates from different regions in China, as reported in our previous studies, seven representative FCV epidemic strains were selected and tested for their viral titers, virulence, immunogenicity, and extensive cross-protection. Subsequently, vaccine strains were selected to prepare inactivated vaccines. The whole-genome sequencing and analysis results showed that these seven representative FCV strains and 144 reference strains fell into five groups (A, B, C, D, and E). The strains isolated in China mainly fall into groups C and D, exhibiting regional characteristics. These Chinese isolates had a distant evolutionary relationship and low homology with the current FCV-255 vaccine strain. The screened FCV-HB7 and FCV-HB10 strains displayed desirable in vitro culture characteristics, with the highest virus proliferation titers (109.5 TCID50/mL) at 36 h post inoculation at a dose of 0.01 MOI. All five cats infected intranasally with FCV-HB7 or FCV-HB10 strains showed obvious clinical symptoms of FCV. The symptoms of cats infected with the FCV-HB7 strain were more severe than those infected with the FCV-HB10 strain. Both the single-strain inactivated immunization and combined bivalent inactivated vaccine immunization of FCV-HB7 and FCV-HB10 induced high neutralizing antibody titers in five cats immunized. Moreover, bivalent inactivated vaccine immunization protected cats from FCV-HB7 and FCV-HB10 strains. The cross-neutralizing antibody titer against seven representative FCV epidemic strains achieved by combined bivalent inactivated vaccine immunization was higher than that achieved by single-strain immunization, which was much higher than that achieved by commercial vaccine FCV-255 strain immunization. The above results suggest that the FCV-HB7 and FCV-HB10 strains screened in this study have great potential to become vaccine strains with broad-spectrum protective efficacy. However, their immune protective efficacy needs to be further verified by multiple methods before clinical application.
Collapse
Affiliation(s)
- Longlong Cao
- Wuhan Keqian Biology Co., Ltd., Wuhan 430070, China; (L.C.); (Y.L.); (Q.Y.); (Q.L.); (W.D.); (J.L.); (Z.Y.); (D.Z.)
- National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China
| | - Jian Liu
- Shanghai Animal Disease Prevention and Control Center, Shanghai 201103, China;
| | - Yongfan Li
- Wuhan Keqian Biology Co., Ltd., Wuhan 430070, China; (L.C.); (Y.L.); (Q.Y.); (Q.L.); (W.D.); (J.L.); (Z.Y.); (D.Z.)
- National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China
| | - Denglong Xie
- Zhejiang Hisun Animal Healthcare Products Co., Ltd., Hangzhou 311400, China;
| | - Quanhui Yan
- Wuhan Keqian Biology Co., Ltd., Wuhan 430070, China; (L.C.); (Y.L.); (Q.Y.); (Q.L.); (W.D.); (J.L.); (Z.Y.); (D.Z.)
- National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China
| | - Qiuyan Li
- Wuhan Keqian Biology Co., Ltd., Wuhan 430070, China; (L.C.); (Y.L.); (Q.Y.); (Q.L.); (W.D.); (J.L.); (Z.Y.); (D.Z.)
- National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China
| | - Yiran Cao
- Department of Life Science, Imperial College London, London SW7 2AZ, UK;
| | - Wenxin Du
- Wuhan Keqian Biology Co., Ltd., Wuhan 430070, China; (L.C.); (Y.L.); (Q.Y.); (Q.L.); (W.D.); (J.L.); (Z.Y.); (D.Z.)
- National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China
| | - Jiakang Li
- Wuhan Keqian Biology Co., Ltd., Wuhan 430070, China; (L.C.); (Y.L.); (Q.Y.); (Q.L.); (W.D.); (J.L.); (Z.Y.); (D.Z.)
- National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China
| | - Zijun Ye
- Wuhan Keqian Biology Co., Ltd., Wuhan 430070, China; (L.C.); (Y.L.); (Q.Y.); (Q.L.); (W.D.); (J.L.); (Z.Y.); (D.Z.)
- National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China
| | - Dengyuan Zhou
- Wuhan Keqian Biology Co., Ltd., Wuhan 430070, China; (L.C.); (Y.L.); (Q.Y.); (Q.L.); (W.D.); (J.L.); (Z.Y.); (D.Z.)
- National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China
| | - Chao Kang
- Wuhan Keqian Biology Co., Ltd., Wuhan 430070, China; (L.C.); (Y.L.); (Q.Y.); (Q.L.); (W.D.); (J.L.); (Z.Y.); (D.Z.)
| | - Shengbo Cao
- Wuhan Keqian Biology Co., Ltd., Wuhan 430070, China; (L.C.); (Y.L.); (Q.Y.); (Q.L.); (W.D.); (J.L.); (Z.Y.); (D.Z.)
- National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China
| |
Collapse
|
2
|
Dall’Ara P, Lauzi S, Turin L, Servida F, Barbieri L, Zambarbieri J, Mazzotti G, Granatiero F, Scarparo E, Mirabile A, Bo S, Filipe J. Prevalence of Serum Antibody Titers against Core Vaccine Antigens in Italian Cats. Life (Basel) 2023; 13:2249. [PMID: 38137850 PMCID: PMC10744740 DOI: 10.3390/life13122249] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2023] [Revised: 11/15/2023] [Accepted: 11/20/2023] [Indexed: 12/24/2023] Open
Abstract
Feline core vaccines strongly recommended for all cats are against Feline panleukopenia virus (FPV), Felid herpesvirus type 1 (FeHV-1), and Feline calicivirus (FCV), but cats can be classified as low- and high-risk based on their lifestyle. The aim of this study was to determine the actual seroprotection against FPV, FeHV-1, and FCV in a large cohort of Italian cats by using the VacciCheck test. A total of 740 cats (567 owned and 173 stray cats; 435 vaccinated and 305 unvaccinated) were analyzed for Protective Antibody Titers (PATs). Differences related to origin, sex, age, breed, FIV/FeLV status, health status, and time elapsed since last vaccination were evaluated. Less than half of the entire cohort (36.4%) had PATs for all three diseases simultaneously, increasing to 48.6% if weak positive values were also considered and 50.3% when considering only the 435 vaccinated cats. Particularly, antibodies were detected against FCV, FPV, and FeHV-1 at protective titers (PATs) in 78.6%, 68.1, and 49.1% of the cats, respectively. In general, owned, neutered, and adult FIV- and/or FeLV-negative cats were the most protected categories, even if not always for the three viruses. Most cats maintained high PATs for 3 years or longer after vaccination against FPV and FCV but not FeHV-1. Long-lasting protective immunity persisted for many years after the last vaccination (more than 18 years in the oldest cats). Nevertheless, since not all cats were protected after so many years and for all pathogens, checking protection via antibody titration could be the best choice to prevent immunity breakdowns. The discussion also focuses on the reliability of antibody titration for the two URTD (upper respiratory tract disease) viruses which, unlike for FPV, is not widely accepted as a valid index of protection.
Collapse
Affiliation(s)
- Paola Dall’Ara
- Department of Veterinary Medicine and Animal Sciences (DIVAS), University of Milan, Via dell’Università 6, 26900 Lodi, LO, Italy (J.F.)
| | - Stefania Lauzi
- Department of Veterinary Medicine and Animal Sciences (DIVAS), University of Milan, Via dell’Università 6, 26900 Lodi, LO, Italy (J.F.)
| | - Lauretta Turin
- Department of Veterinary Medicine and Animal Sciences (DIVAS), University of Milan, Via dell’Università 6, 26900 Lodi, LO, Italy (J.F.)
| | - Francesco Servida
- Clinica Veterinaria Pegaso, Via Dante Alighieri 169, 22070 Rovello Porro, CO, Italy
| | - Laura Barbieri
- Clinica Veterinaria Turro, Via Gerolamo Rovetta 8, 20127 Milano, MI, Italy
| | - Jari Zambarbieri
- Department of Veterinary Medicine and Animal Sciences (DIVAS), University of Milan, Via dell’Università 6, 26900 Lodi, LO, Italy (J.F.)
| | - Giulia Mazzotti
- Ambulatorio Veterinario Mazzotti, Via Papa Giovanni XXIII 93, 24054 Calcio, BG, Italy
| | | | - Elena Scarparo
- Department of Veterinary Medicine and Animal Sciences (DIVAS), University of Milan, Via dell’Università 6, 26900 Lodi, LO, Italy (J.F.)
| | - Aurora Mirabile
- Department of Veterinary Medicine and Animal Sciences (DIVAS), University of Milan, Via dell’Università 6, 26900 Lodi, LO, Italy (J.F.)
| | - Stefano Bo
- Ambulatorio Veterinario Bo-Ferro, Via Fratelli Calandra 3, 10123 Torino, TO, Italy
| | - Joel Filipe
- Department of Veterinary Medicine and Animal Sciences (DIVAS), University of Milan, Via dell’Università 6, 26900 Lodi, LO, Italy (J.F.)
| |
Collapse
|
3
|
Cao L, Li Q, Shi K, Wei L, Ouyang H, Ye Z, Du W, Ye J, Hui X, Li J, Cao S, Zhou D. Isolation and phylogenetic analysis of feline calicivirus strains from various region of China. Animal Diseases 2022. [DOI: 10.1186/s44149-022-00047-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
AbstractFeline calicivirus (FCV) is an important feline pathogen mainly causing upper respiratory tract disease, conjunctivitis, and stomatitis, and it is classified into genotype I and genotype II. To investigate the prevalence and molecular characteristics of FCV, this study collected 337 cat swab samples from animal hospitals in different regions of China from 2019 to 2021. The positive detection rate of FCV was 29.9% (101/337) by RT-PCR. Statistical analysis showed that FCV prevalence was significantly associated with living environment (p = 0.0004), age (p = 0.031) and clinical symptoms (p = 0.00), but not with sex (p = 0.092) and breed (p = 0.171). The 26 strains of FCV were isolated using F81 cells. Phylogenetic analysis showed that 10 isolates belonged to genotype I, and 16 isolates belonged to genotype II. These 26 isolates were highly genetically diverse, of which HB7 isolate had three same virulence-related amino acid loci with VSD strains. Potential loci distinguishing different genotypes were identified from 26 isolates, suggesting the genetic relationship between different genotypes. In addition, selection pressure analysis based on capsid protein of 26 isolates revealed that the protein is under diversifying selection. This study reveals the genetic diversity of FCV and provides a reference for the screening of vaccine candidate strains and the development of vaccines with better cross-protection effects.
Collapse
|
4
|
Hofmann-Lehmann R, Hosie MJ, Hartmann K, Egberink H, Truyen U, Tasker S, Belák S, Boucraut-Baralon C, Frymus T, Lloret A, Marsilio F, Pennisi MG, Addie DD, Lutz H, Thiry E, Radford AD, Möstl K. Calicivirus Infection in Cats. Viruses 2022; 14:937. [PMID: 35632680 PMCID: PMC9145992 DOI: 10.3390/v14050937] [Citation(s) in RCA: 17] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2022] [Revised: 04/24/2022] [Accepted: 04/25/2022] [Indexed: 02/04/2023] Open
Abstract
Feline calicivirus (FCV) is a common pathogen in domestic cats that is highly contagious, resistant to many disinfectants and demonstrates a high genetic variability. FCV infection can lead to serious or even fatal diseases. In this review, the European Advisory Board on Cat Diseases (ABCD), a scientifically independent board of experts in feline medicine from 11 European countries, presents the current knowledge of FCV infection and fills gaps with expert opinions. FCV infections are particularly problematic in multicat environments. FCV-infected cats often show painful erosions in the mouth and mild upper respiratory disease and, particularly in kittens, even fatal pneumonia. However, infection can be associated with chronic gingivostomatitis. Rarely, highly virulent FCV variants can induce severe systemic disease with epizootic spread and high mortality. FCV can best be detected by reverse-transcriptase PCR. However, a negative result does not rule out FCV infection and healthy cats can test positive. All cats should be vaccinated against FCV (core vaccine); however, vaccination protects cats from disease but not from infection. Considering the high variability of FCV, changing to different vaccine strain(s) may be of benefit if disease occurs in fully vaccinated cats. Infection-induced immunity is not life-long and does not protect against all strains; therefore, vaccination of cats that have recovered from caliciviral disease is recommended.
Collapse
Affiliation(s)
- Regina Hofmann-Lehmann
- Clinical Laboratory, Department of Clinical Diagnostics and Services, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland;
| | - Margaret J. Hosie
- MRC—University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK;
| | - Katrin Hartmann
- Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine, Ludwig Maximilian University of Munich, 80539 Munich, Germany;
| | - Herman Egberink
- Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, University of Utrecht, 3584 CL Utrecht, The Netherlands;
| | - Uwe Truyen
- Institute of Animal Hygiene and Veterinary Public Health, University of Leipzig, 04103 Leipzig, Germany;
| | - Séverine Tasker
- Bristol Veterinary School, University of Bristol, Bristol BS40 5DU, UK;
- Linnaeus Veterinary Limited, Shirley, Solihull B90 4BN, UK
| | - Sándor Belák
- Department of Biomedical Sciences and Veterinary Public Health (BVF), Swedish University of Agricultural Sciences (SLU), P.O. Box 7036, 750 07 Uppsala, Sweden;
| | | | - Tadeusz Frymus
- Department of Small Animal Diseases with Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences—SGGW, 02-787 Warsaw, Poland;
| | - Albert Lloret
- Fundació Hospital Clínic Veterinari, Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain;
| | - Fulvio Marsilio
- Faculty of Veterinary Medicine, Università degli Studi di Teramo, 64100 Teramo, Italy;
| | - Maria Grazia Pennisi
- Dipartimento di Scienze Veterinarie, Università di Messina, 98168 Messina, Italy;
| | - Diane D. Addie
- Veterinary Diagnostic Services, School of Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1QH, UK;
| | - Hans Lutz
- Clinical Laboratory, Department of Clinical Diagnostics and Services, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland;
| | - Etienne Thiry
- Veterinary Virology and Animal Viral Diseases, Department of Infectious and Parasitic Diseases, Fundamental and Applied Research for Animals & Health Research Centre, Faculty of Veterinary Medicine, Liège University, B-4000 Liège, Belgium;
| | - Alan D. Radford
- Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Leahurst Campus, Chester High Road, Neston CH64 7TE, UK;
| | - Karin Möstl
- Institute of Virology, Department for Pathobiology, University of Veterinary Medicine, 1210 Vienna, Austria;
| |
Collapse
|
5
|
Hosie MJ, Hofmann-Lehmann R. Special Issue: Viral Infections in Companion Animals. Viruses 2022; 14. [PMID: 35215913 DOI: 10.3390/v14020320] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2022] [Accepted: 02/01/2022] [Indexed: 11/17/2022] Open
Abstract
Companion animals, such as cats, dogs, horses and exotic species, play an important role in society; more than 600 million cats and 900 million dogs live closely with humans worldwide [...].
Collapse
|